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Introduction
Hematopoiesis is the differentiation of hematopoietic stem cells into all types of blood cells, a process that is highly conserved among vertebrates (Hsu et al., 2001; de Jong and Zon, 2005) . Although primitive hematopoiesis predominantly produces erythroid and myeloid cells in mammals and zebrafish, erythroid and myeloid cell lineages seem to develop in spatially distinct regions in zebrafish. Erythroid cells are differentiated in the ICM derived from the posterior lateral plate mesoderm (PLPM), whereas myeloid cells are generated in the anterior lateral plate mesoderm (ALPM) under the developing central nervous system (Berman et al., 2005) . Conservation of molecular structure and corresponding lineage-specific expression pattern of myeloid-specific genes (lyz and l-plastin, etc.) and erythroid-specific genes (heme synthesis enzymes and globins, etc.) between teleosts and mammals implies the existence of shared genetic pathways that regulate the vertebrate hematopoietic development.
Recent published data suggest that hematopoietic cell lineage differentiation is controlled by the specific activation and/or repression of critical transcriptional factors (Orkin, 2000; Nagamura-Inoue et al., 2001 ). In zebrafish erythropoiesis, gata1 and biklf for the expression of erythroid-lineage specific genes that often contain GATA binding motif and CACCC site (Krü ppel-like factor binding site) in their promoter regions (Lyons et al., 2002; Kawahara and Dawid, 2001; Huber et al., 2001) . We have recently shown that biklf cooperates with gata1 for the regulation of a heme synthesis enzyme coproporphyrinogen oxidase (Hanaoka et al., 2006) .
In the case of mammalian myelopoiesis, it has been shown that PU.1/SPI-1 (an ETS family gene) and C/EBP family members play a pivotal role in myelopoiesis (NagamuraInoue et al., 2001; Friedman, 2007) . Pu.1 deficient mice exhibit myeloid and lymphoid developmental defects (Scott et al., 1994) . Conservation of pu.1 function is noted in zebrafish as the knockdown of pu.1 results in the suppression of myeloid markers, mpo and l-plastin. In mice, disruption of C/EBPa leads to the impairment of neutrophils and eosinophils (Wang et al., 1995) . However, the contribution of c/ebp members is still obscure in zebrafish myelopoiesis (Lyons et al., 2001a,b) . Additionally, members of the RUNX family transcriptional factors are also candidate myeloid regulators, as the disruptions of these factors severely affect mammalian hematopoiesis (Westendorf and Hiebert, 1999) . In humans, the loss-offunction mutation in RUNX1/AML1 results in acute myeloid leukemia (AML) (Preudhomme et al., 2000) . In zebrafish, the knockdown of runx1 results in defects in vasculature and accumulation of immature hematopoietic precursors (KalevZylinska et al., 2002; Burns et al., 2005; Gering and Patient, 2005) , whereas the function of runx1 in zebrafish myelopoiesis is not fully resolved. The expression of lyz in zebrafish is highly restricted in myeloid cells (Liu and Wen, 2002) , however, the regulatory mechanism of lyz expression is not fully understood. Since myeloid-lineage specific genes may be regulated by the coordinate activation of transcriptional factors including Pu.1, C/ebp family and Runx family members, in vivo promoter analysis of lyz using zebrafish embryos could better define the cooperative contribution of myeloid-lineage transcriptional factors.
In this study, using transient and stable expression of the reporter construct (pTol-lyzP [2.4 kb]-EGFP), we showed that the zebrafish lyz 2.4 kb promoter sequence possesses potent myeloid-specific expression activity. Knockdown and overexpression analysis of transcriptional factors expressed in myeloid cells provides evidence of the requirement of pu.1, runx1 and c/ebp1 for the efficient expression of lyz during zebrafish myelopoiesis.
Results

2.1.
Isolation of the lyz promoter that controls myeloidspecific expression lysozyme C (lyz) is predominantly expressed in myeloid cells during embryogenesis. To address the transcriptional regulatory mechanism controlling lyz gene expression, we isolated the promoter region of lyz from zebrafish genomic DNA by PCR. The 2.4 kb genomic fragment upstream of the translational initiation site of the lyz gene was linked to EGFP in the pTol-EGFP vector that contains the Tol2 transposable element (Fig. 1A) (Urasaki et al., 2006) . pTol-lyzP (2.4 kb)-EGFP DNA (25 pg) and synthetic Tol2 transposase RNA (25 pg) were co-injected into one-cell stage embryos. We scored EGFP expression to determine whether EGFP reflected the promoter activity in myeloid cells (transient EGFP expression assay). More than 60% of embryos injected with the 2.4 kb promoter construct (Fig. 1C) displayed EGFP-positive cells specifically detected in developing myeloid cells at 24 h post-fertilization (hpf) (Fig. 1B) , whereas a small number of EGFP-positive cells were observed in the 0.5 kb promoter construct-injected embryo. EGFP-positive cells appeared to behave as myeloid cells as evidenced by the observation that the cells migrated into various tissues after blood circulation started (Fig. 5B , Supplementary Movie). The EGFP expression noted in the lyz promoter-injected embryos was highly analogous to the lyz expression pattern (Figs. 1 and 3) , suggesting that the 2.4 kb lyz promoter is sufficient to recapitulate the myeloid-specific lyz expression profile.
To characterize its regulatory mechanism, promoter activity was examined by transient EGFP expression assay using a series of deletion constructs of the 2.4 kb promoter (Fig. 1C) . Comparable promoter activities were observed in the 2.4-, 2.2-, 2.1-and 1.9-kb promoter-injected embryos. In contrast, the number of EGFP-positive cells drastically decreased in the 1.7-, 1.4-and 0.5-kb promoter-injected embryos (Fig. 1C) . Hence, the results of the promoter analysis predict that the presence of critical cis-element(s) for lyz expression is located between À1.9 kb and À1.7 kb.
2.2.
Identification of critical cis-elements in the lyz promoter
To identify cis-elements required for the myeloid-specific lyz expression, we searched putative transcriptional factor binding sites using the database TFSEARCH, (http:// mbs.cbrc.jp/research/db/TFSEARCH.html). The search identified thirteen C/ebp family, two Runx family and one Ets family (Pu.1) putative binding sites in the 2.4 kb promoter sequence. Importantly, three C/ebp family and one Runx putative binding sites were located between À1.95 kb and À1.65 kb ( Fig. 2A) .
To examine the contribution of the identified sites for myeloid-specific expression, we designed a series of deletion mutant constructs as shown in Fig. 2A and examined the transient EGFP expression of deletion constructs after injection. Removal of promoter region between À1.69 kb and À1.74 kb resulted in a drastic reduction of EGFP-positive cells in myeloid cells (Fig. 2B) , suggesting that the Runx binding site in this region is a candidate cis-element essential for the myeloid enhancer activity. We next generated an internal deletion mutant lacking only the Runx site (TGTGGT at À1.70 kb) and examined the transient EGFP expression upon injection. We found a substantial decrease of EGFP-positive cells in the Runx mutant promoter-injected embryos (Fig. 2C) , indicating the Runx site is critical for the lyz expression in myeloid cells. Further, we created internal deletion constructs lacking the C/ebp family binding site (TTTGGCAAT at 1.46 kb or TCAGCAAA at 0.14 kb, which is highly homologous to the C/ebp binding consensus) or the Ets family site (ATTTCCTAT at 0.48 kb; a candidate for Pu.1 binding site) in the 2.4 kb promoter. Substantial reduction of EGFP expression by the deletion of C/ebp site at À1.46 kb was observed, whereas the deletion of C/ebp site at À0.14 kb or Ets/Pu.1 binding site at À0.48 kb did not affect EGFP expression (Fig. 2C ). In addition, the deletion of the proximal region (from À1.4 kb to À0.5 kb) in the 2.4 kb promoter or the addition of C/ebp1 and Runx1 biding sites to the minimal 0.5 kb promoter presented myeloid-specific EGFP expression with similar extent to that of the 2.4 kb lyz promoter (Fig. 2C ). These results indicate that both the Runx binding site at À1.70 kb and the C/ebp binding site at À1.46 kb play important roles for efficient myeloid-specific lyz expression.
To examine whether Runx1, C/ebp1 and Pu.1 could bind to the 2.4 kb lyz promoter, we performed DNA pull-down analysis using EGFP-fusion proteins of myeloid-lineage transcriptional factors (EGFP-runx1, EGFP-c/ebp1, EGFP-pu.1 and EGFP-IRF8). EGFP-fusion constructs were transfected into HEK293T and cell lysates were incubated with biotinated 2.4 kb lyz promoter fragment (F) or mutant promoter fragment. Subsequently, proteins binding to the lyz promoter were precipitated by streptavidin beads and detected by western blotting using anti-EGFP antibody. As shown in Fig. 2D , EGFP-runx1 associated with the 2.4 kb lyz promoter (F), but not the runx site deletion promoter (DR). EGFP-c/ebp1 strongly associated with the 2.4 kb lyz promoter (F), while EGFP-c/ebp1 weakly associated with the mutant promoter (DC) in which the c/ebp site at À1.46 kb was deleted but other putative twelve c/ebp sites were intact. Further, EGFP-pu.1 but not EGFP-IRF8 co-precipitated with the 2.4 kb lyz promoter (Fig. 2D ). These results suggest that Runx1, C/ebp1 and Pu.1 can directly regulate the lyz expression during myelopoiesis.
pu.1 is required for efficient expression of runx1 and c/ebp1 in myeloid cells
We examined the contribution of myeloid-lineage transcription factors to regulation of lyz gene expression by knockdown analysis. pu.1 is essential for zebrafish myelopoiesis and is required for lyz gene regulation. lyz expression is suppressed in pu.1 morphants (inhibition; 85%, n = 40) (Fig. 3B ) as previously reported (Rhodes et al., 2005) . Since c/ebp1 is specifically expressed in developing myeloid cells and is a novel uncharacterized C/ebp family protein, we designed c/ebp1 morpholinos ( Supplementary Fig. 1 ) and examined the contribution of c/ebp1 to lyz gene regulation. We found that lyz expression was completely suppressed in c/ebp1 morphants (inhibition; 94%, n = 66) (Fig. 3C) ; which is consistent with a recent report using different c/ebp1 morpholinos (Su et al., 2007) . In zebrafish, three groups have reported that runx1 is required for hematopoietic development, because the expression of cmyb is suppressed in embryos that were injected with runx1 morpholinos (Kalev-Zylinska et al., 2002; Gering and Patient, 2005; Burns et al., 2005) . Since the function of runx1 in zebrafish myelopoiesis remains unclear, we further examined lyz expression in runx1 morphants. The expression of lyz was inhibited in runx1 morphants (inhibition; 74%, n = 42) (Fig. 3D) . Knockdown analysis suggests that runx1, c/ebp1 and pu.1 are required for lyz expression, however, mutual transcriptional regulation among them remains undetermined. Therefore, we examined the expression of these genes in runx1 MO-, c/ebp1 MO-and pu.1 MO-injected embryos. The expression of c/ebp1 was significantly suppressed in pu.1 morphants (inhibition; 100%, n = 24), and to a lesser extent in runx1 morphants (inhibition; 28%, n = 21) (Fig. 3E-G) . The runx1 expression in myeloid cells, but not in the ICM and Rohonbeard cells, was selectively inhibited in pu.1 morphants (inhibition in myeloid cells; 95%, n = 20) (Fig. 3H and I) ; which is consistent with a previous report (Rhodes et al., 2005) . The runx1 expression was not affected in c/ebp1 morphants (inhibition; 10%, n = 31) (Fig. 3J) . On the other hand, the pu.1 expression in both runx1 morphants (inhibition; 0%, n = 20) and c/ebp1 morphants (inhibition; 0%, n = 26) was unaffected ( Fig. 3K-M) . These results indicate that pu.1 is required for proper expression of c/ebp1 and runx1 in myeloid cells.
2.4.
Ectopic lyz expression by co-injection of runx1, c/ebp1 and pu.1 lyz expression was definitively suppressed in pu.1 MO-, c/ ebp1 MO-and runx1 MO-injected embryos. In contrast, ectopic expression of lyz was not observed with injection of individual mRNAs (data not shown). Therefore, we asked whether these genes cooperatively function to promote lyz expression. Injection of runx1 (100 pg) and pu.1 (10 pg) (expansion; 0%, n = 50), and of runx1 (100 pg) and c/ebp1 (100 pg) (expansion; 0%, n = 43) did not affect the lyz expression (Fig. 4A) . In contrast, ectopic lyz expression in the ICM was weakly detected when both c/ebp1 (100 pg) and pu.1 (10 pg) mRNAs were co-injected (expansion; 30%, n = 48). Furthermore, injection of triple mRNAs (runx1 [100 pg] + c/ebp1 [100 pg] + pu.1 [10 pg]) resulted in strong ectopic lyz expression in the ICM (expansion; 59%, n = 37) (Fig. 4A) , whereas the expression of erythroid markers gata1 and band3 was not affected (Fig. 4B) . These results suggest that pu.1, c/ebp1 and runx1 cooperatively regulate lyz expression.
2.5.
Establishment of Tg(lyz:EGFP)
We established three transgenic lines Tg(lyz:EGFP) expressing EGFP driven by the 2.4 kb lyz promoter. A small number of (Fig. 5A) , and expression was maintained at 3 days post-fertilization (dpf) (Fig. 5B) . We found that most EGFP-positive cells localized in various tissues, and observed that EGFP-positive cells circulating in blood vessels were a minor population (Supplementary Movie). The EGFP expression in Tg(lyz:EGFP) ko02 completely overlapped with endogenous lyz transcripts ( Fig. 5C-E) . Further, runx1, c/ebp1 and pu.1, but not gata1 were detected in EGFP-positive cells sorted from Tg(lyz:EGFP) ko02 (Supplementary Fig. 2) . Knockdown of runx1, c/ebp1 or pu.1 suppressed EGFP expression in Tg(lyz:EGFP) ko02 (Fig. 5A vs F-H 55%, n = 20) (Fig. 5A vs I) . Results obtained from analysis of Tg(lyz:EGFP) ko02 were consistent with the idea that the 2.4 kb lyz promoter is sufficient to recapitulate myeloid-specific lyz expression.
Ectopic lyz expression in the ICM by suppression of erythroid-lineage factors biklf and gata1
Recent studies present a hypothesis that the balance of myeloid-lineage transcriptional factors and erythroid-lineage transcriptional factors controls cell fates of myeloid and erythroid lineages, respectively (Rhodes et al., 2005; Galloway et al., 2005) . It has been shown that loss of gata1 transformed primitive erythroid precursors into myeloid cells in zebrafish (Galloway et al., 2005) . We previously demonstrated that biklf cooperated with gata1 to regulate erythroid development (Kawahara and Dawid, 2001) .
To investigate whether depletion of biklf affects the expression of myeloid marker genes, we performed knockdown analysis of biklf using the embryos from vlad tepes (vlt)/gata1 mutant fish (Lyons et al., 2002) . As previously reported (Galloway et al., 2005) , the pu.1 expression was substantially increased in the ICM of vlt/gata1 mutant embryos (Fig. 6A vs  B) . On the other hand, pu.1 expression was slightly increased in the ICM of biklf morphants (Fig. 6A vs C) . We found that Fig. 6 -Suppression of erythroid-lineage factors biklf and gata1 strongly induces ectopic lyz expression in the ICM. (A-P) All embryos are around 24 hpf and lateral view; anterior is left. Morpholinos (biklf MO; 10 ng) were injected into one-cell stage embryos from wild-type or vlad tepes (vlt)/gata1 mutant, and the expression of myeloid markers was examined by wholemount in situ hybridization; marker is shown at bottom right. Genome DNA was prepared from the stained embryos after taking pictures, and genotyping of vlt was performed. The myeloid markers, pu.1, c/ebp1, runx1 and lyz are expressed in myeloid cells over the yolk (orange arrowheads) (A, E and M). The expression of pu.1, c/ebp1, runx1 and lyz was weakly induced in the ICM (red arrowheads) in vlt embryos or biklf MO-injected embryos. When biklf MO was injected into vlt embryos, the markers (pu.1, c/ebp1, runx1 and lyz) were strongly induced in the ICM (red arrowheads). .
M E C H A N I S M S O F D E V E L O P M E
N T 1 2 6 ( 2 0 0 9 ) 3 1 4 -3 2 3 c/ebp1, runx1 and lyz were weakly induced in the ICM of vlt/ gata1 mutant embryos (Fig. 6E, I , M vs F, J, N). Similarly, weak induction of pu.1, c/ebp1, runx1 and lyz was observed in biklf morphants (Fig. 6A, E, I , M vs C, G, K, O). Importantly, inhibition of both gata1 and biklf resulted in the significant induction of pu.1, c/ebp1, runx1 and lyz in the ICM (Fig. 6A, E , when gata1 MO (10 ng) and biklf MO (10 ng) were co-injected (Fig. 6Q vs R) . These results suggest that both gata1 and biklf cooperate to suppress the expression of myeloid marker genes in the ICM. On the contrary, co-injection of pu.1 MO and c/ebp1 MO in embryos derived from Tg(gata1:mRFP) ko05 led to the weak induction of mRFP in the ALPM as well in the ICM (Fig. 6S vs T) . Knockdown analysis for erythroid-and myeloid-lineage transcription factors suggests that gata1 and biklf have a mutually antagonistic relationship with pu.1 and c/ebp1 in zebrafish.
Discussion
In this study we isolated a 2.4 kb promoter region of zebrafish lyz and analyzed the molecular mechanisms controlling lyz gene expression during zebrafish myelopoiesis. Both transient and stable expression of a reporter construct pTol-lyzP (2.4 kb)-EGFP containing the 2.4 kb zebrafish lyz promoter fused to EGFP, presented a myeloid-specific EGFP expression in zebrafish (Figs. 1 and 5) . Indeed, EGFP expression in Tg(lyz:EGFP) ko02 overlapped with endogenous lyz expression ( Fig. 5C-E) . At the onset of blood circulation, EGFP-positive cells spread and migrated in various tissues in Tg(lyz:EGFP)-
ko02
. Further, tail abscission of transgenic embryos and injection of mRFP-labeled bacteria near the heart of Tg(lyz:EGFP) ko02 embryos led to the accumulation of EGFP-positive cells at the inflammation sites (data not shown). These findings are fully consistent with a recent report of transgenic lines containing the 6 kb promoter region of zebrafish lyz gene (Hall et al., 2007) , indicating that the 2.4 kb promoter as well as the 6 kb promoter are sufficient for the efficient myeloidspecific lyz expression in zebrafish.
3.1. The Runx binding site at À1.70 kb and the C/ebp binding site at À1.46 kb are necessary for the lyz expression in myeloid cells
To identify the cis-elements critical for myeloid-specific lyz expression, we performed a transient EGFP reporter expression assay using pTol-lyzP (2.4 kb)-EGFP. Internal deletion constructs lacking the Runx site (TGTGGT at À1.70 kb) or the C/ebp site (TTTGGCAAT at À1.46 kb) drastically diminished the myeloid-specific expression activity in the 2.4 kb lyz promoter (Fig. 2C) . Although we cannot rule out the possibility that other Runx and C/ebp sites also contribute the full activation of lyz promoter in myeloid cells, both Runx (À1.70 kb) and C/ebp (À1.46 kb) sites are indispensable for the effective lyz promoter activation. In mice, Runx1 is involved in myeloid and lymphoid development (Okuda et al., 1996) , while the function of runx1 in myelopoiesis is unknown in zebrafish. On the other hand, c/ebp1 is a novel C/ebp member in zebrafish, because C/ebp1 possesses a unique N-terminal domain in addition to bZIP domain highly homologous among mammalian C/EBPs. Expression of a chimeric molecule containing the N-terminal domain of C/ebp1 fused to the GAL4 DNA binding domain strongly activated a GAL4 reporter, therefore, C/ebp1 was thought to act as transcriptional activator (Lyons et al., 2001b) . Interestingly, knockdown of runx1 or c/ebp1 strongly suppressed lyz expression (Fig. 3) and the Runx site (À1.70 kb) and the C/ebp site (À1.46 kb) are essential for the lyz gene regulation, raising the possibility that both runx1 and c/ebp1 regulate the lyz promoter during zebrafish myelopoiesis.
3.2.
pu.1 plays a pivotal role in controlling lyz expression
Since the deletion of a highly conserved Ets/Pu.1 binding site (ATTTCCTAT at À0.48 kb) in the 2.4 kb lyz promoter did not affect the myeloid-specific EGFP expression (Fig. 2C) , we could not explain the importance of the Ets/Pu.1 site in the 2.4 kb lyz promoter. To examine whether there are unidentified Pu.1 cis-elements within the 2.4 kb lyz promoter, we performed a DNA pull-down assay using the biotinated 2.4 kb lyz promoter and an EGFP-pu.1 construct. We found that EGFPpu.1 co-precipitated with the 2.4 kb lyz promoter, suggesting that Pu.1 can bind to the lyz promoter. In chicken, a PU.1 binding site is required for full activation of Lysozyme gene (Faust et al., 1999) . Therefore, further analysis is required to identify the uncharacterized Pu.1 responsive element(s) in the zebrafish lyz promoter. In addition, the DNA pull-down analysis showed that EGFP-runx1 and EGFP-c/ebp1, but not EGFP-IRF8, interacted with the 2.4 kb lyz promoter. Consistent with these binding activity results, lyz expression was suppressed in pu.1 MO-, c/ebp1 MO-and runx1 MO-injected embryos (Fig. 3) , whereas the lyz expression was not affected in IRF8 Fig. 7 -Model of lyz regulation in zebrafish myelopoiesis. pu.1 is required for the expression of c/ebp1 and runx1 in myeloid cells. Since pu.1, c/ebp1 and runx1 interact with the 2.4 kb lyz promoter, these factors cooperatively regulate lyz expression, presumably through the Runx site (at À1.7 kb) and C/ebp site (at À1.46 kb) and uncharacterized Ets/Pu.1 site(s). Antagonistic function between myeloid-lineage transcription factors (pu.1 and c/ebp1) and erythroid-lineage transcription factors (gata1 and biklf) may define the lyz expression domain during early embryogenesis.
MO-injected embryos (data not shown). Further, knockdown of pu.1 resulted in inhibition of runx1 and c/ebp1 expression in addition to lyz expression in myeloid cells (Fig. 3) . Since pu.1 is initially expressed in the ALPM including myeloid precursors (Lieschke et al., 2002) , pu.1 may function in the specification of myeloid-lineage, presumably through the induction of myeloid-lineage transcription factors such as runx1 and c/ebp1 (Fig. 7) . Interestingly, we found that forced expression of pu.1, runx1 and c/ebp1 resulted in the ectopic expansion of lyz in the ICM (Fig. 4) , whereas injection of individual mRNAs did not affect the lyz expression. We, therefore, propose the cooperative contribution of pu.1, runx1 and c/ebp1 to lyz expression during zebrafish myelopoiesis (Fig. 7) .
3.3.
Erythroid-lineage transcriptional factors gata1 and biklf negatively regulate lyz expression
It is an interesting question as to why erythroid and myeloid cells develop in spatially distinct regions in the zebrafish embryo. It has been proposed that the differentiation of myeloid and erythroid cells is mediated by the balance between pu.1 and gata1, which mutually and negatively regulate the gene expression of each other in zebrafish (Rhodes et al., 2005) . We previously reported that biklf as well as gata1 contributes to the regulation of zebrafish erythropoiesis (Kawahara and Dawid, 2001) , therefore, we examined the antagonistic function of biklf and gata1 in myeloid development. We found that the weak induction of pu.1, c/ebp1, runx1 and lyz was observed in biklf morphants (Fig. 6) . Further, the expression of pu.1, c/ebp1, runx1 and lyz significantly increased in the ICM when the function of biklf and gata1 were simultaneously inhibited (Fig. 6) . Consistently, ectopic EGFP expression in the ICM was observed in gata1 MO-and biklf MO-injected Tg(lyz:EGFP) embryos. Importantly, overexpression of pu.1, runx1, and c/ebp1 induced endogenous lyz expression and EGFP expression of Tg(lyz:EGFP) in the ICM (Fig. 6) . These results suggest that both biklf and gata1 negatively regulate the function of pu.1, runx1 and c/ebp1 in the ICM where erythroid cells are mainly generated. On the other hand, mRFP expression in the ALPM as well as the ICM was slightly increased in pu.1 MO-and c/ebp1 MO-injected embryo from Tg(gata1:mRFP). Our results strengthen the previous model (Rhodes et al., 2005) that the erythroid regulators gata1 and biklf antagonize the function of pu.1 and c/ebp1, which regulate myeloid-specific genes including lyz during zebrafish hematopoiesis (Fig. 7) .
4.
Materials and methods
4.1.
Isolation of lyz promoter from zebrafish genomic DNA Zebrafish genomic DNA was prepared from adult fin of AB strain by standard methods. Genome information about the 2.4 kb upstream sequence of the initiation codon of lyz gene was obtained from the database of zebrafish draft genomic sequence (Sanger Institute). The upstream region (2.4 kb) of lyz promoter was amplified from the zebrafish genomic DNA by PCR using the following primers containing restriction enzyme sites (SfiI or NcoI): SfiI-lyzP 2.4k primer; 5 0 -AC 
TCCGTCATCGCTGAGTGT-3 0 ) were obtained from Gene Tools, LLC. For construction of C/ebp1-N-terminal-EGFP, the 5 0 -UTR and N-terminal domain (amino acids 1-69) of c/ebp1 containing morpholino target sites were fused to EGFP. Synthetic mRNAs encoding runx1, pu.1, c/ebp1 and Tol2 transposase were transcribed in vitro using mMESSAGE mMACHINE kit (Ambion) according to manufacture's instruction. Plasmid DNAs, morpholinos and synthetic mRNAs were dissolved in injection buffer (40 mM Hepes [pH 7.4], 240 mM KCl, and 0.5% phenol red). Plasmid DNAs and mRNAs were injected into the blastomere(s) of one-or two-cell stage zebrafish embryos, and morpholinos were injected into the yolk or blastomere(s) of one-or two-cell stage embryos.
DNA pull-down assay
The 2.4 kb lyz promoter was subcloned into pBluescript II vector (pBS-2.4 k-lyz). To prepare biotinated 2.4 kb lyz promoter fragments, PCR was performed with biotinated T3 and T7 primer against pBS-2.4 kb-lyz. HEK293T cells were transfected with EGFP-fusion constructs (EGFP-pu.1, EGFPrunx1, EGFP-c/ebp1 or EGFP-IRF8) using FuGENE (Roche). After 48 h, transfected cells were incubated with DNA pull-down buffer (20 mM Hepes-KOH [pH7.4], 80 mM KCl, 1 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 10% glycerol, 0.1% Triton X-100, 0.1 mM PMSF) at 4°C. The cell lysates (500 ll) were incubated with the biotinated lyz promoter fragments (1 lg), polydIdC (50 lg) and streptavidin-conjugated magnet beads (Dynabeads M-280 streptavidin). Bound proteins were separated by SDS-PAGE and were detected by western blotting with an anti-EGFP polyclonal antibody (Invitrogen).
4.4.
Whole-mount in situ hybridization
Anti-sense RNA probes for lyz, runx1, pu.1, c/ebp1, band3 and gata1 labeled with digoxigenin (DIG) were prepared using the RNA labeling kit (Roche). Whole-mount in situ hybridization was performed as previously described (Hanaoka et al., 2006) . Color reaction was carried out using BM purple (Roche) as substrate. For double in situ hybridization, one probe was labeled with DIG and detected by AP-conjugated anti-DIG antibody and HNPP fluorescent detection set (Roche), and the other probe was labeled with fluorescein (Roche) and detected by POD-conjugated anti-fluorescein antibody (Roche) and fluorescein-tyramide. To create the fluorescein-tyramide, NHS-fluorescein (Pierce) was reacted with tyramide (Sigma).
Establishment of transgenic zebrafish
Both pTol-lyzP (2.4 kb)-EGFP DNA and Tol2 transposase mRNA were co-injected into one-cell stage embryos, and all injected embryos were raised to adulthood. These fish were mated with wild-type fish, and we isolated three independent transgenic zebrafish lines, Tg(lyz:EGFP) ko02 , Tg(lyz:EGFP) ko03 and Tg(lyz:EGFP) ko04 that stably expressed EGFP in developing myeloid cells. We also generated Tg(gata1:mRFP) ko05 transgenic zebrafish using pTol-gata1P-(8.1 kb)-mRFP by a similar procedure described above.
Mutant and wild-type zebrafish
Mutant alleles of vlad tapes (vlt) m651 were used (Lyons et al., 2002) . Genotyping of vlt was performed by PCR as previously described (Hanaoka et al., 2006) . Wild-type zebrafish strains AB and Riken-Wako were used for injection assay.
RT-PCR analysis
The embryos from Tg(lyz:EGFP) ko02 at 1dpf were incubated with L-15 medium (Gibco) including Dispase II (1000 lm/ml) and EGFP-positive cells were corrected by a cell sorter (BD FACS Aria). Subsequently, total RNA was prepared by Trizol reagent (Invitrogen) and reverse-transcribed as described previously (Kawahara et al., 2002) . runx1, c/ebp1, pu.1, gata1 and EF1a were amplified by PCR using the following primers: runx1-S; 
